Effects of maternal HF diet and absence of TRPC1 gene on mouse placental growth and fetal intrauterine growth retardation (IUGR)

• Published in: The Journal of nutritional biochemistry Vol. 114; no. C; p. 109162
• Main Authors: Claycombe-Larson, Kate, Singh, Brij, Bundy, Amy N., Brunelle, Dale, Bukowski, Michael R., Roemmich, James N.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-04-2023; Elsevier
• Subjects: Animals; Diet, High-Fat - adverse effects; Female; Fetal Growth Retardation - etiology; Fetal Growth Retardation - metabolism; Fetus - metabolism; Humans; intracellular calcium; Lipids; Male; Maternal HF diet; Mice; Placenta - metabolism; Placental and fetal growth; Placentation; Pregnancy; RNA, Messenger - metabolism; TRPC1; Vascular Endothelial Growth Factor A - metabolism; Maternal HF diet; lipids; intracellular calcium; Placental and fetal growth; TRPC1
• ISSN: 0955-2863; 1873-4847
• DOI: 10.1016/j.jnutbio.2022.109162

Placental tissue intracellular calcium (Ca2+) regulates placental development and growth. Maternal high-fat diet (HFD) results in placental lipid accumulation, increased inflammation, reduced nutrient transport expression, and intrauterine growth restriction (IUGR). Currently, whether maternal HFD differentially affects placental and fetal growth and development under reduced Ca2+ influx is not yet known. We hypothesized that maternal HFD feeding decreases placental growth and development resulting in IUGR and that reduction of Ca2+ influx in the placenta worsens maternal HFD-induced placental dysfunction and IUGR. Three-week-old female B6129SF2/J wild type (WT) and transient receptor potential canonical 1 (TRPC1) protein deficient (KO) mice were fed normal fat (NF, 16 kcal % fat) and high fat (HF, 45 kcal % fat) diets for 12 weeks prior to mating with NF diet fed male mice. Fetuses and placentae were examined at mid- (D12) and late- (D18) gestation. At D12, maternal HFD had no effects on placental or fetal weight changes in WT and TRPC1 KO mice while absence of TRPC1 resulted in decreased placental and fetal weights. At D18, maternal HFD increased placental weights in both TRPC1 KO and WT mice, in part, by moderately increasing placental tissue triacylglyceride (TAG, P=.0632). At D12, mRNA expression of key placental growth factors including IGF1, PLGF, and VEGF were increased in WT compared to TRPC1 KO mice while IGF2 and VEGF mRNA expression were increased at D18. Results presented in our study demonstrated that maternal HFD increased placental weight, in part, due to increased lipid concentration resulting in IUGR and via an additive adverse effect of genotype and maternal HFD. Future studies are needed to determine the signaling mechanism underlying Ca2+ influx reduction-induced placental dysfunction and IUGR.